Search

Author/Creator Cherry, Laura

1. S0888 Alternative Subcutaneous Biologic Dosing in Inflammatory Bowel Disease Is Delayed Depending on Insurance Approval Requirements. (October 2020)

Authors:
Coe, Christopher; Cherry, Laura; Shah, Nisha; Zuckerman, Autumn D.; DeClercq, Joshua; Choi, Leena; Donoho, Charles; Pabla, Baldeep S.; Scoville, Elizabeth; Dalal, Robin; Beaulieu, Dawn; Schwartz, David A.; Horst, Sara
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1
Page Start:
S458
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S833 Delay in Insurance Approval of Biologic Therapy Dose Escalation Is Associated With Increased Disease Activity in Patients With Inflammatory Bowel Disease. (October 2021)

Authors:
Shah, Nisha; DeClercq, Josh; Cherry, Laura; Zuckerman, Autumn; Vimalathas, Praveen; Choi, Leena; Donoho, Charles A.; Pabla, Baldeep; Scoville, Elizabeth; Dalal, Robin; Beaulieu, Dawn; Schwartz, David; Horst, Sara
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗